ArticleCancer immunology, immunotherapy : CII2022

Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.

Chisato Yokota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.